Olwexya (Venlafaxine)

Venlafaxine, the active ingredient in Olwexya, is a serotonin‑norepinephrine reuptake inhibitor presented as a tablet for oral use. It is prescribed for major depressive disorder and other mood‑related conditions in adults.

GNH USA supplies Olwexya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olwexya (venlafaxine) acts on neurotransmitter pathways that influence mood and anxiety. It is indicated for: - Major Depressive Disorder: alleviates depressive symptoms and improves functional outcomes. - Generalized Anxiety Disorder: reduces excessive worry and associated physical symptoms. - Social Anxiety Disorder: lessens fear of social situations and improves social functioning.

Venlafaxine may cause a range of adverse reactions.

Common Side Effects: - Nausea - Dry mouth - Headache - Insomnia - Dizziness - Sweating

Serious or Rare Side Effects: - Hypertensive crisis   i   t  \  \

There   t ...

  g